Novavax cut to Underperform by B of A

 In a significant development for Novavax (NVAX, Financial), B of A Securities has downgraded the stock's rating from "Neutral" to "Underperform" as of August 20, 2025. Analyst Alec Stranahan also adjusted the price target for NVAX, lowering it from $9.00 to $7.00 USD, representing a 22.22% decrease.

https://www.gurufocus.com/news/3071110/novavax-nvax-downgraded-by-b-of-a-securities-with-price-target-lowered-nvax-stock-news